Dishman Carbogen Amcis balance sheet

As of Mar 2026

Total assets: ₹11,923cr+19.2% on Mar 2025
Shareholders' equity: ₹6,677cr+14.5% on Mar 2025
Total debt: ₹2,775cr+33.2% on Mar 2025
Cash and investments: ₹804cr+119.4% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2,942	2,684	2,459	1,961
	275	252	501	996
	4.6	4.1	4.3	4.6
	4,798	4,054	3,911	3,864
	104	77.8	78.2	88.6
	295	215	145	47.0
	75.3	72.0	78.9	72.1
	1.9	1.7	47.5	47.4
	149	26.3	22.0	22.8
	227	99.9	148	142
	83.4	12.8	10.8	14.0
	352	400	396	418
	9,081	7,799	7,653	7,535
	1,019	900	883	804
	16.2	25.4	23.3	177
	673	665	461	590
	788	341	264	132
	203	166	149	57.4
	3.3	3.6	3.4	3.4
	23.4	15.3	13.4	6.2
	1,707	1,217	915	966
	116	83.6	131	149
	2,842	2,200	1,928	1,918
	11,923	9,999	9,581	9,454
Equity
	31.4	31.4	31.4	31.4
	6,646	5,800	5,596	5,778
	6,677	5,832	5,628	5,810
	6,677	5,832	5,628	5,810
Liabilities
	1,535	1,149	246	1,047
	252	15.5	287	324
	1,787	1,165	532	1,370
	428	352	379	233
	11.9	12.3	39.3	74.9
	703	687	449	167
	2,929	2,243	1,399	1,845
	1,241	935	1,719	778
	211	231	244	220
	426	211	245	244
	1,878	1,377	2,207	1,241
	14.3	3.8	31.5	52.5
	88.8	41.8	19.3	3.8
	336	502	296	501
	2,317	1,925	2,555	1,798
	5,246	4,168	3,954	3,644
	11,923	9,999	9,581	9,454
Liabilities — additional as-filed lines
	0.0	26.8	—	—
Trade payables — MSME split
	7.0	7.0	—	—
	204	224	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DCAL₹148.86

Dishman Carbogen Amcis Limited

· Pharma & Health

₹ CrorePeersHIKAL SOLARA PANACEABIO INDSWFTLAB SAIPARENT INDOCO SMSPHARMA WINDLASMcap ₹2,334 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,960.9	2,459.1	2,683.9	2,941.9	2,941.9
+ Capital Work-in-Progress	996.3	500.8	251.7	275.0	275.0
+ Investment Property	4.6	4.3	4.1	4.6	4.6
+ Goodwill	3,863.8	3,910.7	4,053.6	4,798.4	4,798.4
+ Other Intangibles	88.6	78.2	77.8	104.4	104.4
+ Intangibles under Development	47.0	144.9	215.2	295.3	295.3
+ Non-current Investments	72.1	78.9	72.0	75.3	75.3
+ Long-term Loans	47.4	47.5	1.7	1.9	1.9
+ Other Non-current Financial Assets	22.8	22.0	26.3	149.4	149.4
Non-current Financial Assets	142.3	148.3	99.9	226.6	226.6
+ Deferred Tax Assets	14.0	10.8	12.8	83.4	83.4
+ Other Non-current Assets	417.8	396.1	399.8	351.7	351.7
Total Non-current Assets	7,535.1	7,653.2	7,798.7	9,081.2	9,081.2
Current Assets
+ Inventories	803.8	882.9	900.2	1,019.1	1,019.1
+ Current Investments	177.0	23.3	25.4	16.2	16.2
+ Trade Receivables	589.9	461.1	665.1	672.9	672.9
+ Cash & Cash Equivalents	131.8	264.1	341.1	787.8	787.8
+ Other Bank Balances	57.4	149.3	166.0	203.5	203.5
+ Short-term Loans	3.4	3.4	3.6	3.3	3.3
+ Other Current Financial Assets	6.2	13.4	15.3	23.4	23.4
Current Financial Assets	965.6	914.6	1,216.6	1,707.0	1,707.0
+ Other Current Assets	148.9	130.7	83.6	116.0	116.0
Total Current Assets	1,918.4	1,928.2	2,200.4	2,842.1	2,842.1
Total Assets	9,453.5	9,581.4	9,999.2	11,923.3	11,923.3
Equity
+ Equity Share Capital	31.4	31.4	31.4	31.4	31.4
+ Other Equity / Reserves	5,778.3	5,596.1	5,800.2	6,645.5	6,645.5
Equity — Owners of Parent	5,809.7	5,627.5	5,831.5	6,676.9	6,676.9
Total Equity	5,809.7	5,627.5	5,831.5	6,676.9	6,676.9
Liabilities
+ Borrowings — Non-current	1,046.7	245.6	1,149.2	1,534.9	1,534.9
+ Other Non-current Financial Liab	323.7	286.6	15.5	252.1	252.1
Non-current Financial Liabilities	1,370.4	532.2	1,164.7	1,787.0	1,787.0
+ Provisions — Non-current	233.2	379.0	352.4	427.9	427.9
+ Deferred Tax Liabilities	74.9	39.3	12.3	11.9	11.9
+ Other Non-current Liabilities	167.0	448.6	686.7	702.6	702.6
Non-current Liabilities	1,845.4	1,399.2	2,242.8	2,929.4	2,929.4
+ Borrowings — Current	777.9	1,718.8	934.7	1,240.5	1,240.5
+ Trade Payables	219.7	244.1	230.7	211.2	211.2
+ Other Current Financial Liab	243.9	244.6	211.4	426.4	426.4
Current Financial Liabilities	1,241.5	2,207.5	1,376.8	1,878.1	1,878.1
+ Provisions — Current	52.5	31.5	3.8	14.3	14.3
+ Current Tax Liabilities	3.8	19.3	41.8	88.8	88.8
+ Other Current Liabilities	500.7	296.4	502.5	335.8	335.8
Current Liabilities	1,798.4	2,554.7	1,924.8	2,317.1	2,317.1
Total Liabilities	3,643.8	3,953.9	4,167.6	5,246.4	5,246.4
Total Equity & Liabilities	9,453.5	9,581.4	9,999.2	11,923.3	11,923.3
Liabilities — additional as-filed lines
+ Deferred Government Grants — Non-current	—	—	26.8	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	7.0	7.0	7.0
+ Dues to Other Creditors — Current	—	—	223.7	204.2	204.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.